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1. Introduction 
The mechanism of formation of complexes of 
trypsin with naturally-occurring trypsin inhibitors 
requires the participation of a specific lysine or 
arginine residue in the inhibitor molecule. With some 
inhibitors, the specific arginyl or lysyl bond is 
actually cleaved by trypsin in the process of complex 
formation [l-4]. It has been shown [S] that a 
lysine residue of responsible for the activity of cow 
colostrum trypsin inhibitor (CTI). When the free 
amino groups are modified, the inhibitor loses its 
activity. The CT1 molecule consists of a single poly- 
peptide chain of 67 amino acids to which a non- 
protein moiety is bound [6]. There are three free 
amino groups in the chain, two lysine residues in 
positions 18 and 66 and one N-terminal phenylalanine 
[7]. The present paper provides evidence that lysine 
18 plays a role in the activity of this inhibitor. 
2. Materials and methods 
The trypsin inhibitor which occurs in large 
quantities in cow colostrum was used as starting 
material [8]. Trypsin was a twice recrystallized 
product of LCEiva, Prague. The trypsin activity was 
determined by the method of Nagel et al. [9]. The 
activity of the inhibitor was measured by its reaction 
with trypsin [lo] The trypsin-trypsin-inhibitor com- 
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plex was prepared by mixing a solution of the inhibitor 
(15 mg) with trypsin (30 mg) in distilled water and by 
adjusting the pH to 8.2 with ammonium carbonate. 
After the small precipitate had been centrifuged off, the 
clear solution was applied to a 2.5 X 34 cm column 
of Sephadex G-100. The column was eluted with 
0.01 M ammonium carbonate at a rate of 6 ml/hr. 
Fractions containing the pure complex were pooled 
and freeze-dried. 
Free CT1 (7 mg) was carbamylated [5] by 0.3 M 
potassium cyanate in 0.05 M tris-buffer at pH 8.5, 
20 hr at 37”. The CTI-TR (18 mg) complex was 
carbamylated by 0.6 M cyanate in 0.01 M tris-buffer 
at pH 8.5,20 hr at 37”. Guanidination [I l] of both 
the free inhibitor and of the complex was carried out 
in 0.5 M o-methylisourea - 0.01 M - EDTA at pH 
9.5, 70 hr at 25”. Free CT1 (15 mg) was dissolved in 
3 ml, the complex (12 mg) in 2.4 ml. The modified 
proteins were freed of the excess of the reagents by 
desalting on columns of Sephadex G-25 equilibrated 
either with 0.1 M ammonium carbonate (carbamylated 
derivatives) or with 0.2 % formic acid (guanidinated 
derivatives). 
The dissociation of the modified complexes was 
effected by dissolving the complex in distilled water 
and by adding the same volume of 5% trichloroacetic 
acid (TCA). The mixture was allowed to stand 15 min 
at 37”. Precipitated trypsin was centrifuged off and 
the clear solution of the modified inhibitor was freed 
from TCA by desalting on a Sephadex G-25 column 
equilibrated with 0.2% formic acid. The pure in- 
hibitor was freeze-dried. 
The quantitative amino acid composition of the 
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Fig. 1. Peptide maps of tryptic digests of oxidized native 
inhibitor (I), of inhibitor carbamylated in free form (IKb), 
and of inhibitor released from carbamylated complex (IKb’). 
The peptides are numbered with respect to the order of 
tryptic peptides in the molecule [7]. Lysine 18 is at the 
C-terminus of peptide 2, lysine 66 is at theN-terminus of 
peptide 5. The N-terminal peptide marked in black is not 
stained by ninhydrin in IKb and IKb’. The presence of the 
peptide was shown by chlorination. 
native modified inhibitors was measured on a 
Beckman-Spinco amino acid analyzer. 
The disulfide bonds of the native or modified 
inhibitors were cleaved by performic acid oxidation 
[ 131. The oxidized proteins were digested with 
trypsin in distilled water. The pH of the solution 
was adjusted to 8.4 with ammonium carbonate. The 
digestion was allowed to proceed 2 hr at 37”. Peptide 
maps of the tryptic digests of the oxidized proteins 
were obtained by a combination of electrophoresis 
(60 V/cm, pH 1.7, formic acid-acetic acid-water, 
1:3: 16) and descending chromatography (butanol- 
pyridine-acetic acid-water, 30:20:6:24). The 
spots of individual peptides were detected by 0.2% 
ninhydrin and by chlorination [ 141. Peptides 
Table 1 
Analytical values of amino acid residues in native inhibitor 
(I), in inhibitor carbamylated in free form (IKb) or in 
complex (IKb’), and in inhibitor guanidinated in free form 
(IGv) and in complex (I&‘). 
Amino acid I IKb IKb’ IGV IGV’ 
Lysine 2.0 0.6* 1.6* - 1.0 
Arginine 3.0 3.1 3.0 3.2 3.1 
Homocitrulline _ 1.4* 0.3* - - 
Homoarginine - _ _ 1.8 0.9 
* The higher values of lysine and the lower values of homo- 
citrulline in IKb and IKb’ can be accounted for by partial 
decomposition of homocitrulline to lysine during the 
hydrolysis. 
Fig. 2. Peptide maps of tryptic digest of oxidized native 
inhibitor (I), of inhibitor guanidinated in free form (I@), and 
of inhibitor released form the guanidinated complex (IGv’). 
The peptides marked black gave a positive Sakaguchi reaction. 
In peptides marked by an asterisk, the presence of home- 
arginine was determined by quantitative amino acid analysis. 
The peptide (2-3) was formed by incomplete cleavage of the 
bond at the carboxyl side of homoarginine 18. 
containing arginine or homoarginine were stained by 
the Sakaguchi reaction [ 151. The presence of peptides 
bearing a carbamyl group was revealed by the Ehrlich 
reagent by dipping the chromatogram into 0.5% 
benzaldehyde in hydrochloric acid-ethanol( 1:4 v/v). 
In preparative-scale xperiments, the peptide maps 
were dipped into 0.01% ninhydrin in acetone, the 
spots cut out, the products eluted with distilled water 
and subjected to quantitative amino acid analysis. 
3. Results 
The peptide maps of the tryptic digests of the 
oxidized native cow colostrum inhibitor were 
compared with the peptide maps obtained from the 
digests of the inhibitor modified by carbamylation or 
guanidination, either in the free form or as a complex 
with trypsin. As seen in fig. 1 and table 1, both 
lysine residues of the inhibitor which had been 
carbamylated in the free form (IKb) were converted 
to homocitrulline residues. The free N-terminal amino 
group was also carbamylated. When, however, the 
inhibitor was bound to trypsin as a complex during 
carbamylation (IKb’), then lysine 18 remained intact. 
The fully carbamylated derivative lost its ability to 
inhibit trypsin (as assayed with benzoyl-arginine 
p-nitroanilide). In contrast, the activity of the 
derivative with intact lysine 18 was practically the 
same as the activity of the native protein. Guanidina- 
tion of free CT1 converts lysine residues into homo- 
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arginines (fig. 2, table 1). After guanidination of the 
CTI-trypsin complex, lysine 18 again remained intact. 
Both modified proteins retained their activity toward 
trypsin. 
The results presented here show that for CT1 to 
inhibit trypsin, a basic amino acid residue at position 
18 toward which trypsin is sensitive is essential. When 
the inhibitor is bound to trypsin as a complex, lysine 
18 is resistant to the modifying agents. The modifica- 
tion of lysine 66 and of the N-terminal amino acid 
residue does not affect the inhibitory activity of CT1 
towards trypsin. 
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